GlassScriptPhysician profile
Kimberly E Kallin
NPI 1871963736
$356.91
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.42 · 2022: $66.39 · 2023: $134 · 2024: $76.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $49.75 | 2023 | Mepilex Border Flex, Exufiber Ag+, Setopress |
| Kerecis Limited | $49.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $40.67 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Reapplix INC. | $40.52 | 2023 | 3c Patch Kit - Box |
| Smith+Nephew, INC. | $37.95 | 2021-2022 | |
| Convatec INC. | $28.51 | 2022 | |
| Solventum Corporation | $26.53 | 2024 | Activ.A.C. |
| Kci USA, INC. | $26.20 | 2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Bioventus LLC | $21.57 | 2022 | |
| Misonix INC | $20.71 | 2021 | |
| Hartmann USA, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Kallin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.